EUVIMEDSkopri EUVIMED
Crossref

Two‐tier subclassification of the Bethesda category III (atypia of undetermined significance/follicular lesion of undetermined significance) in thyroid cytology

Jay Alden, Denise Lambrou, Jack Yang iD

Diagnostic Cytopathology · 2024

DOI: 10.1002/dc.25261 ↗

At a glance

Journal article in Diagnostic Cytopathology, 2024. Written by Jay Alden and 2 co-authors. Institution: Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USA. Major MEDLINE topics: Thyroid Neoplasms, Thyroid Nodule, Adenocarcinoma, Follicular. Cited 3 times so far (Crossref); 40 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

The Bethesda category III, AUS/FLUS, comprises a heterogeneous group of thyroid lesions with variable risk of malignancy (ROM). This study evaluates ROM in two subgroups of this category based on nuclear atypia and architectural atypia.

Methods

Cases in Bethesda category III were reported based on nuclear atypia (AUS) and architectural atypia (FLUS). ROM was calculated by comparing the cytologic diagnosis to the follow‐up histologic diagnosis.

Results

Among the 610 Bethesda category III cases in this study, 306 (50.2%) and 304 (49.8%) cases were reported as AUS and FLUS, respectively. One hundred and eighty six of 306 AUS (60.8%) and 193 of 304 FLUS (63.5%) cases underwent surgical intervention. ROM of the cases in Bethesda category III was 12.8% if all cases were counted and 20.6% if only surgical cases were counted. When analyzing separately, ROM of AUS cases was 17.0% and 28.0% with all cases and surgical cases only, respectively. For FLUS cases, ROM was 8.6% and 13.5% with all cases and surgical cases only, respectively.

Conclusion

In Bethesda category III, ROM in the cases with nuclear atypia was significantly higher than the cases with architectural atypia. Sub‐classifying the Bethesda Category III cases with nuclear atypia and architectural atypia, respectively may better stratify the ROM.

Subjects

MeSH terms (MEDLINE)

Thyroid NeoplasmsThyroid NoduleAdenocarcinoma, FollicularHumansBiopsy, Fine-NeedleRetrospective StudiesCytodiagnosis

Author keywords

architectural atypiaatypia of undetermined significance/follicular lesion of undetermined significa…nuclear atypiarick of malignancythyroid nodule

Authors and institutions

  • Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.

ORCID profiles: Jack Yang

Cite

APA

Alden, J., Lambrou, D., & Yang, J. (2024). Two‐tier subclassification of the Bethesda category III (atypia of undetermined significance/follicular lesion of undetermined significance) in thyroid cytology. Diagnostic Cytopathology. https://doi.org/10.1002/dc.25261

Vancouver

Alden J, Lambrou D, Yang J. Two‐tier subclassification of the Bethesda category III (atypia of undetermined significance/follicular lesion of undetermined significance) in thyroid cytology. Diagnostic Cytopathology. 2024. doi:10.1002/dc.25261

BibTeX
@article{Alden2024,
  author = {Alden, Jay and Lambrou, Denise and Yang, Jack},
  title = {Two‐tier subclassification of the Bethesda category III (atypia of undetermined significance/follicular lesion of undetermined significance) in thyroid cytology},
  journal = {Diagnostic Cytopathology},
  year = {2024},
  doi = {10.1002/dc.25261}
}
Start for free →